Shaping the future of clinical trials through strategic foresight
Through a collaborative cross-industry effort that prioritizes proactive patient involvement and responsible use of technology, we can shape a clinical trial ecosystem that is inclusive, ethical and ready for the future. We urge all stakeholders to act now on these initiatives to positively influence the future of clinical trials.
Authors
- Keith R. Perry
- Christian Boisvert-Huneault (ORCID: https://orcid.org/0000-0002-2111-2517)
- D. Goldstein (ORCID: https://orcid.org/0000-0003-3654-8142)
- Sharon Lee (ORCID: https://orcid.org/0000-0001-8995-9784)
- Kimberley Kallsen
- Nidhi Swarup (ORCID: https://orcid.org/0000-0003-4083-8388)
- Éric Fakra
- Emmanuelle Clerisme-Beaty
- José Saraiva
- Martin Bauer
- Claas Röhl
- Jan Geissler
- Christopher P Denton
- Manya Lind
- Kazuo Hasegawa
- Allan Flyvbjerg
- Rossana Berardi
- Tracey Robertson
- Jeff McIntyre
- Aron Szpisjak
Institutions
- Marche Polytechnic University (IT)
- Boehringer Ingelheim (Germany) (DE)
- Universidade Estadual de Campinas (UNICAMP) (BR)
- Copenhagen Institute for Futures Studies (DK)
- Danish Medicines Agency (DK)
- Japan Steel Works (Japan) (JP)
- Yale Cancer Center (US)
- Cystic Fibrosis Canada (CA)
- UNSW Sydney (AU)
- AMS (Singapore) (SG)
- Institute Cancer De La Loire Lucien Neuwirth (FR)
- Liver Institute Northwest (US)
- Psoriasis Association (GB)
- Boehringer Ingelheim (United States) (US)
- University College London (GB)
- Medical University of Vienna (AT)
- Pontifícia Universidade Católica de Campinas (BR)
- National Patient Safety Foundation (US)
- Pontifícia Universidade Católica de São Paulo (BR)
Publication Details
- Journal
- Clinical Trials
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1177/17407745251414680
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00